SEC Form 4 · accession 0001213900-26-074238
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jesse Shefferman
Officer — CEO and President · Director
Period of report
Jun 29, 2026
Accepted (ET)
Jul 1, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001359931
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 29, 2026 | M | 215,687 | $1.91 | A | 937,519 | D | |
| Common StockF1 | Jun 29, 2026 | S | 215,687 | $4.09 | D | 721,832 | D | |
| Common Stock | Jun 30, 2026 | G | 14,000 | $0.00 | D | 707,832 | D | |
| Common Stock | Jun 30, 2026 | G | 7,000 | $0.00 | D | 700,832 | D | |
| Common Stock | Jun 30, 2026 | G | 4,000 | $0.00 | D | 696,832 | D | |
| Common Stock | Jun 30, 2026 | G | 5,000 | $0.00 | D | 691,832 | D | |
| Common StockF2,F3 | holding | — | — | — | 300,000 | I | The Samhold Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $1.91 | Jun 29, 2026 | M | 215,687 | D | — | Jan 18, 2034 | Common Stock | 215,687 | 141,313 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.03 to $4.14, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F2The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest, and this report should not be deemed an admission that the Reporting Person or any other person named herein is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- F3The reported securities held by the Samhold Family Trust were inadvertently included under the Reporting Person's direct holdings in the prior Form 4 filings filed by the Reporting Person on January 21, 2026, January 22, 2026 and January 27, 2026.
- F425% of the shares underlying the option vested on January 19, 2025 and the remaining shares have vested or will vest in equal monthly installments thereafter over the following 36 months, subject to the Reporting Person's continuous service with the Issuer as of each such date.